Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation

Gastroenterology

Volumn 129, Issue 1, 2005, Pages 204-219

  Theiss, Arianne L ^a   Fuller, C Randall ^a   Simmons, James G ^a   Liu, Bo ^b   Sartor, R Balfour ^b   Lund, P Kay ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CYTOKINE; MESSENGER RNA; PEPTIDOGLYCAN POLYSACCHARIDE; RECOMBINANT GROWTH HORMONE; SERUM ALBUMIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CECUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTEROCOLITIS; FEMALE; FIBROSIS; GRANULOMA; HISTOLOGY; ILEUM; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SCORING SYSTEM;

EID: 22344444197     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.05.019     Document Type: Article

References (54)

1. E. Zimmermann, P.K. Lund Fibrogenesis R.B. Sartor W.J. Sandborn Kirsner's inflammatory bowel diseases 6th ed. 2004 Elsevier Philadelphia 219 229
2. M.F. Graham, R.F. Diegelmann, C.O. Elson, W.J. Lindblad, N. Gotschalk, S. Gay, R. Gay Collagen content and types in the intestinal strictures of Crohn's disease Gastroenterology 94 1988 257 265
3. H. Matthes, H. Herbst, D. Schuppan, A. Stallmach, S. Milani, H. Stein, E.O. Riecken Cellular localization of procollagen gene transcripts in inflammatory bowel diseases Gastroenterology 102 1992 431 442
4. D.W. Powell, R.C. Mifflin, J.D. Valentich, S.E. Crowe, J.I. Saada, A.B. West Myofibroblasts. II. Intestinal subepithelial myofibroblasts Am J Physiol 277 1999 C183 C201
5. D.W. Powell, R.C. Mifflin, J.D. Valentich, S.E. Crowe, J.I. Saada, A.B. West Myofibroblasts. I. Paracrine cells important in health and disease Am J Physiol 277 1999 C1 C9
6. J.B. Pucilowska, K.K. McNaughton, N.K. Mohapatra, E.C. Hoyt, E.M. Zimmermann, R.B. Sartor, P.K. Lund IGF-I and procollagen alpha1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease Am J Physiol 279 2000 G1307 G1322
7. G. Van Assche, K. Geboes, P. Rutgeerts Medical therapy for Crohn's disease strictures Inflamm Bowel Dis 10 2004 55 60
8. J.M. Becker Surgical therapy for ulcerative colitis and Crohn's disease Gastroenterol Clin North Am 28 1999 371 390 viii-ix
9. J.S. Scolapio, M. Camilleri, C.R. Fleming, L.V. Oenning, D.D. Burton, T.J. Sebo, K.P. Batts, D.G. Kelly Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome a randomized, controlled study Gastroenterology 113 1997 1074 1081
10. L. Ellegard, I. Bosaeus, S. Nordgren, B.A. Bengtsson Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome Ann Surg 225 1997 88 96
11. T.A. Byrne, R.L. Persinger, L.S. Young, T.R. Ziegler, D.W. Wilmore A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet Ann Surg 222 1995 243 254
12. C. Cukier, D.L. Waitzberg, V.C. Borges, L. Silva Mde, J. Gama-Rodrigues, H.W. Pinotti Clinical use of growth hormone and glutamine in short bowel syndrome Rev Hosp Clin Fac Med Sao Paulo 54 1999 29 34
13. D. Seguy, K. Vahedi, N. Kapel, J.C. Souberbielle, B. Messing Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients a positive study Gastroenterology 124 2003 293 302
14. J. Szkudlarek, P.B. Jeppesen, P.B. Mortensen Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients a randomised, double blind, crossover, placebo controlled study Gut 47 2000 199 205
15. J.S. Scolapio Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome a randomized, controlled study JPEN J Parenter Enteral Nutr 23 1999 309 313
16. T.A. Byrne, T.B. Morrissey, T.V. Nattakom, T.R. Ziegler, D.W. Wilmore Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome JPEN J Parenter Enteral Nutr 19 1995 296 302
17. J.S. Scolapio Tales from the crypt Gastroenterology 124 2003 561 564
18. N. Mauras, D. George, J. Evans, D. Milov, S. Abrams, A. Rini, S. Welch, M.W. Haymond Growth hormone has anabolic effects in glucocorticosteroid- dependent children with inflammatory bowel disease a pilot study Metabolism 51 2002 127 135
19. J. Henker Therapy with recombinant growth hormone in children with Crohn's disease and growth failure Eur J Pediatr 155 1996 1066 1067
20. A.E. Slonim, L. Bulone, M.B. Damore, T. Goldberg, M.A. Wingertzahn, M.J. McKinley A preliminary study of growth hormone therapy for Crohn's disease N Engl J Med 342 2000 1633 1637
21. H. Christensen, A. Flyvbjerg, H. Orskov, S. Laurberg Effect of growth hormone on the inflammatory activity of experimental colitis in rats Scand J Gastroenterol 28 1993 503 511
22. E. Kara, H. Sungurtekin, U. Sungurtekin, M. Alkanat, O. Ilkgul The effect of recombinant human growth hormone (rhGH) on trinitrobenzene sulfonic acid-induced colitis in rats an experimental study Inflamm Bowel Dis 10 2004 112 115
23. K.L. Williams, C.R. Fuller, L.A. Dieleman, C.M. DaCosta, K.M. Haldeman, R.B. Sartor, P.K. Lund Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone Gastroenterology 120 2001 925 937
24. S. Fruchtman, J.G. Simmons, C.R. Fuller, C.J. Greenhalgh, P.K. Lund Suppressors of cytokine signaling (SOCS) limit fibrogenic actions of growth hormone and insulin-like growth factor-I in intestinal myofibroblasts Gastroenterology 126 2004 A-138
25. E.A. van Tol, L. Holt, F.L. Li, F.M. Kong, R. Rippe, M. Yamauchi, J. Pucilowska, P.K. Lund, R.B. Sartor Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts Am J Physiol 277 1999 G245 G255
26. R.B. Sartor, H. Herfarth, E.A.F. Van Tol Bacterial cell wall polymer-induced granulomatous inflammation Methods 9 1996 233 247
27. R.B. Sartor, W.J. Cromartie, D.W. Powell, J.H. Schwab Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments Gastroenterology 89 1985 587 595
28. E.R. Greig, D.S. Rampton Management of Crohn's Disease 2003 Martin Dunitz New York
29. E.M. Zimmermann, R.B. Sartor, R.D. McCall, M. Pardo, D. Bender, P.K. Lund Insulinlike growth factor I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis Gastroenterology 105 1993 399 409
30. I.C. Lawrance, C. Fiocchi, S. Chakravarti Ulcerative colitis and Crohn's disease distinctive gene expression profiles and novel susceptibility candidate genes Hum Mol Genet 10 2001 445 456
31. I.C. Lawrance, L. Maxwell, W. Doe Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine Inflamm Bowel Dis 7 2001 16 26
32. B.A. Croker, D.L. Krebs, J.G. Zhang, S. Wormald, T.A. Willson, E.G. Stanley, L. Robb, C.J. Greenhalgh, I. Forster, B.E. Clausen, N.A. Nicola, D. Metcalf, D.J. Hilton, A.W. Roberts, W.S. Alexander SOCS3 negatively regulates IL-6 signaling in vivo Nat Immunol 4 2003 540 545
33. P. Lovato, C. Brender, J. Agnholt, J. Kelsen, K. Kaltoft, A. Svejgaard, K.W. Eriksen, A. Woetmann, N. Odum Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease J Biol Chem 278 2003 16777 16781
34. L.A. Ortiz, J. Lasky, E. Gozal, V. Ruiz, G. Lungarella, E. Cavarra, A.R. Brody, M. Friedman, A. Pardo, M. Selman Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis Am J Respir Crit Care Med 163 2001 244 252
35. G. Guo, J. Morrissey, R. McCracken, T. Tolley, H. Liapis, S. Klahr Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis Am J Physiol 280 2001 F777 F785
36. A. Fox, R.R. Brown, S.K. Anderle, C. Chetty, W.J. Cromartie, H. Gooder, J.H. Schwab Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls Infect Immun 35 1982 1003 1010
37. E.M. Dahly, M.E. Miller, P.K. Lund, D.M. Ney Postreceptor resistance to exogenous growth hormone exists in the jejunal mucosa of parenterally fed rats J Nutr 134 2004 530 537
38. J.H. Park, J.A. Vanderhoof Growth hormone did not enhance mucosal hyperplasia after small-bowel resection Scand J Gastroenterol 31 1996 349 354
39. R.D. McCall, S. Haskill, E.M. Zimmermann, P.K. Lund, R.C. Thompson, R.B. Sartor Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats Gastroenterology 106 1994 960 972
40. K. Ohneda, M.H. Ulshen, C.R. Fuller, A.J. D'Ercole, P.K. Lund Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I Gastroenterology 112 1997 444 454
41. L. Savendahl, L.E. Underwood, K.M. Haldeman, M.H. Ulshen, P.K. Lund Fasting prevents experimental murine colitis produced by dextran sulfate sodium and decreases interleukin-1 beta and insulin-like growth factor I messenger ribonucleic acid Endocrinology 138 1997 734 740
42. D.R. Rosell, K.T. Akama, J. Nacher, B.S. McEwen Differential expression of suppressors of cytokine signaling-1, -2, and -3 in the rat hippocampus after seizure implications for neuromodulation by gp130 cytokines Neuroscience 122 2003 349 358
43. J.G. Simmons, J.B. Pucilowska, T.O. Keku, P.K. Lund IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts Am J Physiol 283 2002 G809 G818
44. G.C. Kaiser, D.B. Polk Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell line Gastroenterology 112 1997 1231 1240
45. T.E. Adams, J.A. Hansen, R. Starr, N.A. Nicola, D.J. Hilton, N. Billestrup Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling J Biol Chem 273 1998 1285 1287
46. R. Starr, T.A. Willson, E.M. Viney, L.J. Murray, J.R. Rayner, B.J. Jenkins, T.J. Gonda, W.S. Alexander, D. Metcalf, N.A. Nicola, D.J. Hilton A family of cytokine-inducible inhibitors of signalling Nature 387 1997 917 921
47. A. Suzuki, T. Hanada, K. Mitsuyama, T. Yoshida, S. Kamizono, T. Hoshino, M. Kubo, A. Yamashita, M. Okabe, K. Takeda, S. Akira, S. Matsumoto, A. Toyonaga, M. Sata, A. Yoshimura CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation J Exp Med 193 2001 471 481
48. M.E. Miller, C.Z. Michaylira, J.G. Simmons, D.M. Ney, E.M. Dahly, J.K. Heath, P.K. Lund Suppressor of cytokine signaling-2 a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation Gastroenterology 127 2004 570 581
49. S. Fruchtman, J.G. Simmons, C.Z. Michaylira, M.E. Miller, C.J. Greenhalgh, D.M. Ney, P.K. Lund Suppressor of cytokine signaling-2 (SOCS-2) modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells Am J Physiol 2005 (in press).
50. R. Fukushima, H. Saito, T. Inoue, K. Fukatsu, T. Inaba, I. Han, S. Furukawa, M.T. Lin, T. Muto Prophylactic treatment with growth hormone and insulin-like growth factor I improve systemic bacterial clearance and survival in a murine model of burn-induced gut-derived sepsis Burns 25 1999 425 430
51. T. Shouda, T. Yoshida, T. Hanada, T. Wakioka, M. Oishi, K. Miyoshi, S. Komiya, K. Kosai, Y. Hanakawa, K. Hashimoto, K. Nagata, A. Yoshimura Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis J Clin Invest 108 2001 1781 1788
52. L.Q. Hong-Brown, C.R. Brown, R.N. Cooney, R.A. Frost, C.H. Lang Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation Am J Physiol 285 2003 E63 E72
53. P.E. Lobie, W. Breipohl, M.J. Waters Growth hormone receptor expression in the rat gastrointestinal tract Endocrinology 126 1990 299 306
54. C.J. Greenhalgh, M.E. Miller, D.J. Hilton, P.K. Lund Suppressors of cytokine signaling relevance to gastrointestinal function and disease Gastroenterology 123 2002 2064 2081